Since Ang II is an important mediator in cardiac remodeling and associated ventricular arrhythmias following myocardial infarction, it stimulates the progression of CH and HF, activation of Pak1 may thus represent a novel cardioprotection strategy in these clinical settings. The gene discussed is AGT; the disease is myocardial infarction.